Trials / Not Yet Recruiting
Not Yet RecruitingNCT06795438
Effects of Green Tea on Cardiometabolic Outcomes
Effects of Green Tea Supplementation on Cardiometabolic Parameters
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Central Lancashire · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Green tea may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Green tea | Green tea tablets 1000mg 1 x per day |
| OTHER | Placebo | Placebo control 1 x blinded placebo tablet per day |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2027-02-01
- Completion
- 2027-06-01
- First posted
- 2025-01-28
- Last updated
- 2025-03-27
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06795438. Inclusion in this directory is not an endorsement.